Skip to main content
Caplight Logo









Anaphero

Anaphero

Private
New York City, New YorkHealthcare & Life Scienceshttps://clarion.ai/

Last Round

Seed

Sep 21, 2026

Total Funding Raised

$20M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Anaphero (operating as Clarion) is a healthcare technology company that provides an AI-powered communication platform to automate patient-facing tasks such as scheduling, billing, and prescription management for health systems.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, NLP & Conversational AI, EHR & EMR, Workflow Automation, Vertical SaaS

Business Model

B2B

Customer Profile

Usage-Based SaaS

AI Layer

Application

Keywords

conversational AIvoice AIpatient engagementelectronic health recordsEHRworkflow automationAI medical scribeusage-based SaaSAI front officehealthcare automationAI agentvertical SaaSpatient schedulingAI healthcareoutcome-based pricing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Anaphero Comparables

Compare Anaphero with similar companies based on industry and business-model similarity.

Anaphero comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Parakeet Health
91%
Cevi
87%
Switchboard, MD
83%

Anaphero Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 21, 2026
SeedMar 1, 2024

Anaphero Investors

Notable investors and investment history

Anaphero investors
InvestorRounds
Sequoia CapitalSeed
Y CombinatorSeed
AccelSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 21, 2026

    $10M round led by Accel.

  • Aug 20, 2026

    Monthly visitors increased 33% MoM.

Anaphero Filings

Explore SEC and related filing metadata, where available.

Anaphero filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Anaphero's valuation, stock price, and market status.

Is Anaphero a public or private company?

Anaphero is a private company.

What is the current stock price of Anaphero?

Anaphero is a private company with no public stock price. No recent secondary market data is available.

How much is Anaphero worth (valuation)?

Valuation information for Anaphero is not publicly available.

Can I buy Anaphero stock?

Anaphero shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Anaphero's last funding round?

Anaphero's most recent funding round was Seed on March 1, 2024.

Who are the main investors in Anaphero?

Key investors in Anaphero include Accel.

Will Anaphero IPO soon?

No public IPO plans have been announced for Anaphero.

How can I track Anaphero secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Anaphero's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range3
Year Founded2023
Last FundingSep 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?